AtriCure, Inc. (ATRC) stock
ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.45+0.43 (+0.78%)
Close on Nov 18, 2026Market cap $2.82BP/E 264.0Yield –
AtriCure revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
AtriCure's revenue for the twelve months ending Jun 30, 2026 was $569.62M, up 13.9% year over year. For fiscal 2025 it was $534.53M, up 14.9% from the year before. Over ten years it grew 15.2% a year on average. The highest annual figure on record is $534.53M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $534.53M | +14.9% |
| FY2024 | Dec 31, 2024 | $465.31M | +16.5% |
| FY2023 | Dec 31, 2023 | $399.25M | +20.8% |
| FY2022 | Dec 31, 2022 | $330.38M | +20.4% |
| FY2021 | Dec 31, 2021 | $274.33M | +32.8% |
| FY2020 | Dec 31, 2020 | $206.53M | -10.5% |
| FY2019 | Dec 31, 2019 | $230.81M | +14.5% |
| FY2018 | Dec 31, 2018 | $201.63M | +15.4% |
| FY2017 | Dec 31, 2017 | $174.72M | +12.6% |
| FY2016 | Dec 31, 2016 | $155.11M | +19.5% |
| FY2015 | Dec 31, 2015 | $129.76M | +20.8% |
| FY2014 | Dec 31, 2014 | $107.45M | +31.2% |
| FY2013 | Dec 31, 2013 | $81.89M | +16.6% |
| FY2012 | Dec 31, 2012 | $70.25M | +9.1% |
| FY2011 | Dec 31, 2011 | $64.40M | +9.1% |
| FY2010 | Dec 31, 2010 | $59.01M | +8.2% |
| FY2009 | Dec 31, 2009 | $54.53M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $153.60M | +12.8% |
| Q1 FY2026 | Mar 31, 2026 | $141.25M | +14.3% |
| Q4 FY2025 | Dec 31, 2025 | $140.50M | +13.1% |
| Q3 FY2025 | Sep 30, 2025 | $134.27M | +15.8% |
| Q2 FY2025 | Jun 30, 2025 | $136.14M | +17.1% |
| Q1 FY2025 | Mar 31, 2025 | $123.62M | +13.6% |
| Q4 FY2024 | Dec 31, 2024 | $124.28M | +16.6% |
| Q3 FY2024 | Sep 30, 2024 | $115.91M | +17.9% |
| Q2 FY2024 | Jun 30, 2024 | $116.27M | +15.2% |
| Q1 FY2024 | Mar 31, 2024 | $108.85M | +16.4% |
| Q4 FY2023 | Dec 31, 2023 | $106.54M | +21.0% |
| Q3 FY2023 | Sep 30, 2023 | $98.29M | +18.1% |
| Q2 FY2023 | Jun 30, 2023 | $100.92M | +19.4% |
| Q1 FY2023 | Mar 31, 2023 | $93.49M | +25.4% |
| Q4 FY2022 | Dec 31, 2022 | $88.03M | +20.2% |
| Q3 FY2022 | Sep 30, 2022 | $83.25M | +18.1% |
| Q2 FY2022 | Jun 30, 2022 | $84.53M | +18.4% |
| Q1 FY2022 | Mar 31, 2022 | $74.58M | +25.8% |
| Q4 FY2021 | Dec 31, 2021 | $73.22M | +26.8% |
| Q3 FY2021 | Sep 30, 2021 | $70.46M | +28.7% |
| Q2 FY2021 | Jun 30, 2021 | $71.38M | +74.8% |
| Q1 FY2021 | Mar 31, 2021 | $59.28M | +11.4% |
| Q4 FY2020 | Dec 31, 2020 | $57.73M | -5.9% |
| Q3 FY2020 | Sep 30, 2020 | $54.76M | -3.3% |
| Q2 FY2020 | Jun 30, 2020 | $40.82M | -30.7% |
| Q1 FY2020 | Mar 31, 2020 | $53.23M | -1.4% |
| Q4 FY2019 | Dec 31, 2019 | $61.32M | +15.9% |
| Q3 FY2019 | Sep 30, 2019 | $56.61M | +13.4% |
| Q2 FY2019 | Jun 30, 2019 | $58.91M | +13.7% |
| Q1 FY2019 | Mar 31, 2019 | $53.97M | +14.8% |
| Q4 FY2018 | Dec 31, 2018 | $52.89M | +14.8% |
| Q3 FY2018 | Sep 30, 2018 | $49.94M | +18.5% |
| Q2 FY2018 | Jun 30, 2018 | $51.80M | +14.5% |
| Q1 FY2018 | Mar 31, 2018 | $46.99M | +13.9% |
| Q4 FY2017 | Dec 31, 2017 | $46.06M | +11.9% |
| Q3 FY2017 | Sep 30, 2017 | $42.15M | +9.9% |
| Q2 FY2017 | Jun 30, 2017 | $45.23M | – |
| Q1 FY2017 | Mar 31, 2017 | $41.27M | – |
| Q4 FY2016 | Dec 31, 2016 | $41.16M | – |
| Q3 FY2016 | Sep 30, 2016 | $38.34M | – |
See a number that looks wrong?